Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Assessing the Cox model assumption as a statistical tool for classifying lymphomasP Morel, B Souleau, F Morschhauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'AdulteM Diviné, E Lepage, J Brière, et al.
JAMA|November 7, 2000
Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trialC Delclaux, E L'Her, C Alberti, et al.
Blood|January 1, 1996
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)O Hermine, C Haioun, E Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphomaA Bosly, E Lepage, B Coiffier, et al.
Blood|March 25, 2000
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trialC Fermé, C Sebban, C Hennequin, et al.
Bone Marrow Transplantation|November 1, 1996
Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancerC Gisselbrecht, J M Extra, J P Lotz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomasK Leroy, C Haioun, E Lepage, et al.
Blood|June 25, 1998
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)C Gisselbrecht, P Gaulard, E Lepage, et al.
Pageof 12